Yousif Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.57M | Sell |
|
|||||
|
2025
Q2 | $4.36M | Sell |
|
|||||
|
2025
Q1 | $3.94M | Sell |
|
|||||
|
2024
Q4 | $5.06M | Sell |
|
|||||
|
2024
Q3 | $4.45M | Sell |
|
|||||
|
2024
Q2 | $5.99M | Sell |
|
|||||
|
2024
Q1 | $6.41M | Sell |
|
|||||
|
2023
Q4 | $6.17M | Sell |
|
|||||
|
2023
Q3 | $5.31M | Sell |
|
|||||
|
2023
Q2 | $4.69M | Sell |
|
|||||
|
2023
Q1 | $5.16M | Buy |
|
|||||
|
2022
Q4 | $6.07M | Buy |
|
|||||
|
2022
Q3 | $5.28M | Sell |
|
|||||
|
2022
Q2 | $5.29M | Buy |
|
|||||
|
2022
Q1 | $4.88M | Buy |
|
|||||
|
2021
Q4 | $4.29M | Buy |
|